Weight-loss weariness and Trump threats wipe $250bn off Novo Nordisk and Eli Lilly
Trump’s push for price cuts and tariffs weighs on ‘obesity franchises’, which have missed out on equity market’s rise
Trump’s push for price cuts and tariffs weighs on ‘obesity franchises’, which have missed out on equity market’s rise